Stock Market & Financial News
Gilead Keeps Writing Bigger Checks—But Can the Drugs Keep Paying for Them?
Gilead's quarterly dividend keeps growing and its HIV cash machine runs hot, but the whole enterprise depends on a single blockbuster drug with a patent expiration already penciled onto a calendar a decade out.
GILD -1.04% Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a cyclical recovery story.
SYK -0.86% Airbus: 1,000 Orders, But Deliveries Flash A Warning
Airbus maintains its market leadership with over 1,000 net orders year-to-date, despite ongoing production ramp-up challenges. July deliveries were flat year-on-year at 67 units, with A330 deliveries paused due to a foreign object issue, now resolved. EADSF's book-to-bill ratio remains robust at 2.6x year-to-date, reflecting strong demand and order inflow across both single-aisle and wide-body segments.
EADSF -2.6% Adobe stock falls 7% as company announces new CEO amid leadership shakeup
Adobe shares ADBE fell nearly 7% on Friday after the software company announced a leadership transition on Thursday. Anil Chakravarthy, president of Adobe's Customer Experience Orchestration business, will become president and chief executive officer on Dec. 1, 2026.
ADBE +0.56% 
Why I Doubled Down On Credo
Credo grew Q1 revenue 115% to $479 million while sustaining 68% gross margin and 49.3% non GAAP net margin. Management expects FY2027 revenue growth above 85%, with optical revenue exceeding $600 million as a second growth engine emerges. DustPhotonics expands Credo across silicon photonics, 800G, 1.6T and NPO, creating multiple opportunities to increase content per connection.
CRDO +7.9% 
Altcoin Fund Inflows Hit $90 Million: XRP Joins Institutional Rotation
Stevenson cautions that the trend must persist across different market conditions before it can be viewed as a durable shift.
LENZ Therapeutics: Still Speculative But Priced For Disasters
LENZ Therapeutics is rated a 'Strong Buy' with a fair value estimate of $21.3, reflecting ~266% upside from current levels. I model peak US Vizz sales at $375M, using a 5-pack annualized purchase rate and 30% market share, with conservative international assumptions. LENZ's speculative nature persists due to single-product risk, high SG&A, uninsured status, and rising competition; position sizing remains limited.
LENZ -1.3% 
Gold Weekly Forecast: Fed uncertainty caps the upside
Gold Weekly Forecast: Fed uncertainty caps the upside
UiPath Tumbles 14% as Guided Slowdown Overshadows Revenue Beat
UiPath (NYSE:PATH | PATH Price Prediction) stock is sinking in Friday morning trading after fiscal second-quarter results delivered a headline beat but the forward guide implied a sharp deceleration.
PATH +3.74% 
PayPay: Inorganic Moves To Capture Structural Tailwinds
I initiate coverage of PayPay Corporation (PAYP) with a Buy, after assessing market trends and corporate developments. PAYP's alliance with Seven & i Holdings unlocks significant digital payment adoption potential in an underpenetrated Japanese market. Acquisition of a 70.2% stake in T&D Financial Life Insurance enables PAYP to leverage its 75M user base for cross-selling financial products, as more Japanese re-assess their wealth management options.
PAYP -3.57% 
ZEC Broke $1,000 for the First Time Following Strong Grayscale ZCSH ETF Inflows
Price Surge: ZEC crossed $1,000 and reached $1,021, driven by strong demand and renewed confidence in the privacy‑focused asset. ETF Impact: ZCSH inflows accelerated Zcash's rally, lifting assets under management from $313.5 million to more than $414 million.
Sprinklr (CXM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Sprinklr (CXM) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
CXM +5.45% 
Why Chevron (CVX) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
CVX +1.42% 
Oscar Health, Inc. (OSCR) Just Overtook the 50-Day Moving Average
Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OSCR broke out above the 50-day moving average, suggesting a short-term bullish trend.
OSCR -3.05% 
Is It Worth Investing in Robinhood Markets (HOOD) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
HOOD -1.2% 
Should You Invest in Rigetti Computing (RGTI) Based on Bullish Wall Street Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
RGTI -0.76% 
Brokers Suggest Investing in QuickLogic (QUIK): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
QUIK +2.64% 
Is Emcor Group (EME) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
EME +1.93% 
Wall Street Analysts See Quanta Services (PWR) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
PWR +3.13% 
Is Kroger (KR) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
KR +1.47% 
Brokers Suggest Investing in AppFolio (APPF): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
APPF +1.86% 
Brokers Suggest Investing in Monday.com (MNDY): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
MNDY +2.36% 
Is Archer Aviation (ACHR) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
ACHR +1.21% 
Is Newmont (NEM) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
NEM -0.58% 
Redwire Climbs 14.3% in Six Months: Is the Stock Still a Buy?
RDW expands its space and defense portfolio as backlog grows, but continued losses and contract execution risks cloud its outlook.
RDW +1.25% 
3 Insurers to Add to Portfolio as AI Transforms Insurance Operations
Travelers, Kinsale Capital and Allstate are using AI, data and technology to improve insurance efficiency, underwriting and growth.
ALL +1.15% 
Credo: The Market Is In Disbelief, But You Shouldn't Be Fooled
Credo Technology stays on the buy list despite a stunning post-earnings de-rating and market skepticism around its optical revenue outlook. CRDO stock's valuation has compressed to 22.5x earnings, with management guiding for >85% growth this fiscal year and no imminent disruption between AEC and optical businesses. Market concerns center on hyperscaler revenue concentration (>60%), potential CapEx slowdown post-FY2028, and whether $600M optical revenue guidance is robust enough.
CRDO +7.9% 
Blue Owl stock may short squeeze as golden cross emerges amid turnaround
Blue Owl stock has staged a strong comeback in recent months, climbing from a low of $7.60 in April to around $11.85 currently. The rally could have further room to run after the stock formed a golden cross and a bullish flag pattern, while fading jitters across the AI sector could provide an additional tailwind.
OWL -1.54% 
Zcash Price Prediction: Confirmed Bullish Pattern Suggests $2,500 Target for ZEC
Zcash (ZEC) is targeting a long-term milestone of $2,500 following a confirmed ascending triangle breakout. Meanwhile, its short-term rally is backed by a historically high shielded supply ratio and heavy short liquidations.
Satoshi-Era Holder Moves 40 BTC Amid New York Property Case
Galaxy Research's official X account said on September 4 that a Bitcoin address dormant since November 5, 2011 moved 40 BTC, worth about $3.09 million, in block 965330. The transaction reactivated a Satoshi-era wallet after nearly 15 years of inactivity. 🌚 Awakened — dormant 14+ years40.00 BTC ($3.09M) untouched since first received 2011-11-05 (14.
